Camp4 Therapeutics (CAMP) Payables (2023 - 2026)

Camp4 Therapeutics (CAMP) posted Payables of $863000.0 for Q1 2026, up 374.18% sequentially from $182000.0 in Q4 2025.

Camp4 Therapeutics (CAMP) Payables (2023 - 2026) Analysis & Trends

Camp4 Therapeutics has reported Payables for 4 years, with the latest figure at $863000.0 in Q1 2026.

Quarterly Payables changed N/A year-over-year to $863000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $863000.0 (changed N/A YoY) and the FY2025 annual result came in at $182000.0, down 84.96% from the prior year.
Payables advanced to $863000.0 in Q1 2026 per CAMP's latest filing, from $182000.0 in the prior quarter.
Over five years, Payables peaked at $3.9 million in Q3 2024 and troughed at $182000.0 in Q4 2025.
A 4-year average of $1.3 million and a median of $1.0 million in 2023 frame the typical range for Payables.
The sharpest annual moves came in 2024 and 2025: Payables climbed 16.12% in 2024, then tumbled 84.96% in 2025.
Over 4 years, Payables stood at $1.0 million in 2023, then advanced by 16.12% to $1.2 million in 2024, then sank by 84.96% to $182000.0 in 2025, then jumped by 374.18% to $863000.0 in 2026.
According to Business Quant data, Payables over the past three periods registered $863000.0, $182000.0, and $585000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Payables (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	429.50 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	1.16 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	1.52 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	88.42 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	470.30 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	3.05 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	35.57 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	108.02 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	428.93 Mn
10	Camp4 Therapeutics	282.48 Mn	282.48 Mn	-	1.09 Mn

Download Data